StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report report published on Saturday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Shares of Cumberland Pharmaceuticals stock opened at $1.12 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.26 and a current ratio of 1.44. Cumberland Pharmaceuticals has a 1-year low of $1.07 and a 1-year high of $2.36. The business has a 50-day moving average of $1.27 and a 200-day moving average of $1.42.
About Cumberland Pharmaceuticals
Featured Articles
- Five stocks we like better than Cumberland Pharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- What is a Dividend King?
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- When to Sell a Stock for Profit or Loss
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.